The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus
LIANG Wei, CAI Ying, ZHANG Li-ling, et al. The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(2): 116-119.
LIANG Wei, CAI Ying, ZHANG Li-ling, et al. The Effect of Qingrehuayuziyin Prescription on Lymphocyte Apoptosis and Expression of Fas and Bcl-2 in Peripheral Blood in the Patients with Systemic Lupus Erythematosus[J]. Chinese journal of experimental traditional medical formulae, 2010, 16(2): 116-119.DOI:
Objective: To investigate the effect of Qingrehuayuziyin prescription on lymphocyte apoptosis and expression of Fas and Bcl-2 in peripheral blood in the patients with systemic lupus erythematosus (SLE). Methods : Eighty patients with SLE were selected and divided randomly into two groups
40 in the therapy group and 40 in control group respectively. Patients were got the treatment of Qingrehuayuziyin prescription combined hormone as therapy group and got hormone treating only as control group. After treating three months
the patients lymphocyte were collected and the rate of apoptosis were detected by flow cytometer. Meanwhile
the expression of Fas and Bcl-2 were analyzed by RT-PCR. Results: After 3 months treating
the rate of lymphocyte apoptosis was decreased significantly in therapy group compared with that in control group and with that in pre-treating(P<0.01). The expression of Fas and Bcl-2
compared with that in control group
were also decreased significantly (P<0.01). Conclusion : Qingrehuayuziyin prescription is useful for treating SLE by suppressing lymphocyte apoptosis
decreasing the level of Fas and Bcl-2 in peripheral blood and further modifying the immune status.